Trending Articles
-
To determine the reliability and practicability of the point-of-care- test (POCT) analyzer, Afinion, for capillary HbA1c testing. To assess the benefits of its implementation on the intra-annual follow up of type 2 diabetic patients. ⋯ Afinion seems to be a good choice for the intra-annual determination of HbA1c when compared to the traditional process due to its accessibility, practicability and efficiency. Professionals should know the limitations of the POCT method in order to consider the validity of the results.
-
In recent years, percutaneous tracheostomy has been performed in patients with adverse conditions such as short neck, obesity, coagulopathy or in emergency. ⋯ We believe that percutaneous tracheostomy in well-trained hands can be used safely for the management of the patient with a difficult airway.
-
Revista clínica española · Feb 2021
National retrospective cohort study to identify risk factors for in-hospital 30-day lethality in laboratory-confirmed cases of influenza.
To identify factors associated with the risk of death in adolescent and adult inpatients with laboratory-positive (reverse-transcription polymerase chain reaction) influenza in Mexico during consecutive influenza seasons (2018-2020). ⋯ Our findings highlight the major relevance of promoting immunization in high-risk individuals, together with ensuring early and effective antiviral management in suspected influenza cases.
-
Since January 1997 the first insulin analogue, lispro has been approved for clinical use in Austria. Insulin lispro has a more rapid onset of action than regular insulin and can therefore be injected immediately before the meal, providing increased therapeutic flexibility for the patients. In many studies a slight decrease in frequency of hypoglycaemic attacks was reported. ⋯ No data have been published as yet on the use of insulin lispro in children under 10 years of age and during pregnancy. Potential advantages and disadvantages of insulin lispro therapy, as well as individual factors pertaining to the patient must be taken into consideration on planing treatment with this new insulin analogue. Patients should be well informed about the different action profile of insulin lispro, especially with regard to exercise.